Superion® Interspinous Spacer Clinical Trial
An Investigational Device Designed To
Treat Moderate Lumbar Spinal Stenosis
Thank you for your interest in the Superion® Interspinous Spacer Clinical Trial. Patient enrollment is now complete in VertiFlex’s pivotal clinical trial. We appreciate your interest in Superion®, but the study is no longer accepting new subjects. Therefore; please follow-up with your local physician on alternative care for your lumbar spinal stenosis condition.
VertiFlex®, Inc. Privacy Policy

This website is owned and operated by VertiFlex®, Inc. (“VertiFlex”), the sponsor of the Superion™ IDE Clinical Study.  The Privacy Policy describes the types of information that may be collected by VertiFlex® from internet users and how that information will be used.  By using this site, you agree to the terms of the Privacy Policy.

Personal Information
Personal information, such as name, age, telephone number, email, zip code, and similar information, is only collected on a voluntary basis.  The user can, if desired, provide their age and answers to a short survey.  If the survey indicates the user may meet the initial criteria for the study, the user can, on a voluntary basis, enter additional personal information (name and contact information) into a data form.  There is no obligation to provide this information, even if you meet the initial study criteria identified in the “Am I a Candidate?” survey.


VertiFlex® will only use personal information, such as name and contact information, so that you may be contacted in order to further discuss potential eligibility in the clinical study and for potential analytical/statistical purposes, or to improve the content and functionality of the website.


VertiFlex® will not disclose personal information to anyone who is not involved in the operation or regulatory
oversight of this clinical study.  Persons involved in the operation of the clinical study include VertiFlex® employees and contracted employees, and study coordinators and physicians participating in the study.  Regulatory oversight agencies include the U.S. Food and Drug Administration (FDA), and Department of Health and Human Services (DHHS).


VertiFlex® will not distribute or sell personal information to affiliates or third parties unless compelled to do so by law, by a court order, subpoena, search warrant, legal process or regulation.

Anonymous Information/Usage Data

Additional anonymous information may also be collected to help VertiFlex® understand, for example, the number of users visiting the website, the specific pages visited, the date and time the website was viewed and the domain name from which you access the internet.  This anonymous information cannot identify you or be tied to you.  It will only help VertiFlex® gather information about viewing trends.  VertiFlex® may share anonymous information, such as cumulative statistics, with board members, contracted employees, and third parties at VertiFlex®’s discretion

VertiFlex® takes reasonable steps to protect your personal information from loss or misuse.  Please consider, however, that internet transmission of data may not be 100% secure and you should carefully consider the information you plan to transmit through data forms or email.

This website is not intended for use by children under the age of 13.  VertiFlex® does not knowingly collect information from children in this age group.  If you think that a child has provided VertiFlex® with personal information, please contact VertiFlex® using the contact information listed below.

Updates to Privacy Policy
VertiFlex® may, in its sole discretion, update this Privacy Policy at any time, by posting the amended Privacy Policy on this website.  The amended Privacy Policy shall be effective upon posting, and your access to this website following an update shall be deemed consent to the revised Privacy Policy.

Contact Information
If you would like to communicate with VertiFlex® regarding privacy issues or if you have questions about this Privacy Policy, please forward such communications to .